| Literature DB >> 34252309 |
Laurent Poirel1,2,3, Mustafa Sadek1,4, Patrice Nordmann1,2,3,5.
Abstract
Cefiderocol (FDC) is a recently developed siderophore cephalosporin showing excellent antibacterial activity against Gram-negative bacteria, including Acinetobacter baumannii. By investigating a series of A. baumannii clinical isolates with elevated MICs of FDC, we showed that PER-like β-lactamases and, to a lesser extent, NDM-like β-lactamases, significantly contributed to reduced susceptibility to that antibiotic. Interestingly, we showed that combination of FDC with avibactam exhibited excellent activity against all multidrug-resistant isolates coproducing OXA-23 and PER-type β-lactamases.Entities:
Keywords: Acinetobacter baumannii; NDM; PER; PER-type β-lactamase; beta-lactamase; cefiderocol; susceptibility testing
Mesh:
Substances:
Year: 2021 PMID: 34252309 PMCID: PMC8448131 DOI: 10.1128/AAC.00877-21
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191